Amicus Therapeutics Ownership | Who Owns Amicus Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Amicus Therapeutics Ownership Summary


Amicus Therapeutics is owned by 56.73% institutional investors, 0.69% insiders, and 42.59% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.54% of FOLD shares. Vanguard Health Care Inv is the top mutual fund, with 6.78% of its assets in Amicus Therapeutics shares.

FOLD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmicus Therapeutics56.73%0.69%42.59%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de32.52M10.54%$463.15M
Vanguard group29.70M9.63%$422.97M
Wellington management group llp28.63M9.30%$225.60M
Blackrock24.37M8.05%$241.77M
Avoro capital advisors15.03M4.88%$118.40M
State street14.83M4.81%$211.23B
William blair investment management10.63M3.45%$151.34M
Vestal point capital, lp9.75M3.17%$76.83M
Geode capital management7.35M2.38%$104.62M
Point72 asset management7.16M2.32%$56.39M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Palo alto investors lp5.37M7.83%$42.30M
Cibra capital210.80K5.15%$3.00B
Cm management370.00K4.44%$5.27M
Sovereign's capital management834.43K3.57%$6.58M
Vestal point capital, lp9.75M3.47%$76.83M
Prosight management, lp1.15M3.38%$16.38M
Athos capital600.00K3.27%$8.54M
Chicago capital management400.00K2.92%$4.28M
Soleus capital management5.21M2.74%$74.15M
Iron triangle partners lp1.97M2.21%$15.53M

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de32.52M0.01%6.68M
Soros fund management5.00M0.82%5.00M
Ubs group5.89M0.01%4.16M
Point72 asset management7.16M0.09%3.88M
State street14.83M0.01%3.27M

Top Sellers

HolderShares% AssetsChange
William blair investment management10.63M0.42%-5.12M
Pictet asset management sa1.99M0.03%-4.79M
Macquarie group---4.56M
American century companies---3.90M
Massachusetts financial services co /ma/125.52K0.00%-3.58M

New Positions

HolderShares% AssetsChangeValue
Soros fund management5.00M0.82%5.00M$71.20M
Iron triangle partners lp1.97M2.21%1.97M$15.53M
Norges bank1.17M0.00%1.17M$16.59M
Ubs oconnor1.00M1.66%1.00M$14.24M
Alpine associates management949.20K0.90%949.20K$13.52M

Sold Out

HolderChange
Skopos labs-22.00
Cva family office-43.00
Capital performance advisors llp-43.00
Svb wealth-44.00
Innealta capital-47.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025205-33.01%174,980,941-44.00%560.55%121-25.77%45-49.44%
Sep 30, 2025166-39.19%134,937,657-54.68%430.47%101-32.21%43-46.25%
Jun 30, 2025279-4.78%319,193,5204.06%1031.04%1520.66%81-3.57%
Mar 31, 2025293-2.98%309,463,7181.44%1001.00%1522.01%83-17.82%
Dec 31, 2024144-52.32%151,685,331-50.57%490.49%60-59.46%59-35.16%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Health Care Inv20.89M6.78%-
Vanguard Total Stock Mkt Idx Inv9.51M3.08%-200.71K
Vanguard US Total Market Shares ETF9.38M3.05%10.28K
Vanguard Small Cap Index7.47M2.42%-48.88K
iShares Russell 2000 ETF6.55M2.12%-124.42K
Macquarie Small Cap Core I5.62M1.82%614.64K
Delaware Small Cap Core I5.13M1.73%-31.80K
SPDR® S&P Biotech ETF5.04M1.64%124.19K
Janus Henderson Opportunistic Alpha MA4.58M1.54%4.58M
Janus Henderson US Opportunistic Alpha4.58M1.54%-565.02K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 20, 2026Campbell Bradley L President and CEOSell$1.07M
Dec 19, 2025Clark David Michael Chief People OfficerSell$363.38K
Dec 15, 2025Campbell Bradley L President and CEOSell$846.01K
Dec 15, 2025Clark David Michael Chief People OfficerSell$282.07K
Dec 01, 2025Campbell Bradley L President and CEOSell$146.01K

Insider Transactions Trends


DateBuySell
2026 Q1-1
2025 Q4-10
2025 Q3--
2025 Q2--
2025 Q1-1

FOLD Ownership FAQ


Who Owns Amicus Therapeutics?

Amicus Therapeutics shareholders are primarily institutional investors at 56.73%, followed by 0.69% insiders and 42.58% retail investors. The average institutional ownership in Amicus Therapeutics's industry, Biotech Stocks , is 382.11%, which Amicus Therapeutics falls below.

Who owns the most shares of Amicus Therapeutics?

Amicus Therapeutics’s largest shareholders are Blackrock funding, inc. /de (32.52M shares, 10.54%), Vanguard group (29.7M shares, 9.63%), and Wellington management group llp (28.63M shares, 9.30%). Together, they hold 29.47% of Amicus Therapeutics’s total shares outstanding.

Does Blackrock own Amicus Therapeutics?

Yes, BlackRock owns 8.05% of Amicus Therapeutics, totaling 24.37M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.77M$. In the last quarter, BlackRock increased its holdings by 1.52M shares, a 6.66% change.

Who is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.83% of its assets in 5.37M Amicus Therapeutics shares, valued at 42.3M$.

Who is the top mutual fund holder of Amicus Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Amicus Therapeutics shares, with 6.78% of its total shares outstanding invested in 20.89M Amicus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools